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Objectives: The ability to form biofilms contributes significantly to the virulence of 
Staphylococcus aureus. Virulence factors may be associated with certain S. aureus 
lineages. However, the contribution of the genetic background of S. aureus to biofilm 
formation is poorly understood. This study investigated the association between the 
genetic background and the biofilm forming ability of clinical invasive S. aureus 
isolates. Secondary objectives included investigating any correlation with biofilm 
formation and methicillin resistance or the source of bacteraemia. 
 
Methods: The study was conducted at a 1300-bed tertiary hospital in Cape Town, 
South Africa. S. aureus isolates obtained from blood cultures between January 2010 
and January 2012 were included. Genotypic characterization was performed by 
PFGE, spa typing, SCCmec typing and MLST. Thirty genotypically unique strains 
were assessed for phenotypic biofilm formation with the microtitre plate assay. All 
isolates were tested in triplicate and an average optical density, measured at a 
wavelength of 490nm, was determined. The biofilm forming ability of isolates with 
A490 > 0.17 was considered ‘weak positive’ and A490 > 0.34 ‘strong positive’. Isolates 
with A490 ≤ 0.17 were considered non-adherent. ANOVA with Bonferroni-adjusted 
post-hoc tests and t-tests were used for statistical analysis of the association between 
biofilm forming ability and strain characteristics.  
 
Results: Fifty seven percent of isolates were capable of forming biofilms. Weak 
biofilm formation occurred in 40% (n=12) and strong biofilm formation in 17% (n=5) 
of isolates. Thirteen (43%) of the isolates were classified as non-adherent. All 5 
isolates capable of strong biofilm formation belong to one spa clonal complex (spa-
CC 064). Strains from spa-CC 064 were capable of higher biofilm formation than 
other spa clonal complexes (p=0.00002). These 5 strains belonged to MLST CC5 and 
CC8. Biofilm formation did not correlate with methicillin resistance and was not 
related to the source of bacteraemia.  
 
Conclusion: Biofilm formation correlates with the spa clonal lineage in our 
population of invasive S. aureus strains. High biofilm formation was associated with 
spa-CC 064. MLST CC5 and CC8 strains are capable of strong biofilm formation. 
 




















Staphylococcus aureus has ensured its success as an important pathogen worldwide 
through its versatility, virulence factors and resistance mechanisms. Invasive S. 
aureus infections have a high mortality rate and infections with methicillin-resistant S. 
aureus (MRSA) have even poorer outcomes (Lowy, 1998; Cosgrove & Fowler, 
2008). Biofilm formation is a major virulence factor of S. aureus.  
 
A biofilm is ‘an assemblage of surface-associated microbial cells that is encased in an 
extracellular polymeric substance matrix’ (Donlan, 2002). These unique communities 
form on various indwelling medical devices. Bacteria embedded in a biofilm are more 
resistant to antimicrobials through several mechanisms. Overall antimicrobial 
penetration is poor, growth-dependent agents have decreased efficacy due to the 
slower metabolic state of the bacteria and exchange of resistance genes is easier due 
to the close proximity of cells. Formation of persister-cells, a subpopulation of 
bacteria that survive antimicrobial treatment, is also a contributing factor (Cramton & 
Gotz, 2004).  
 
Due to advances in the medical field, prosthetic devices are increasingly used in 
patient management.  Biofilms may develop on intravascular catheters, prosthetic 
heart valves and orthopaedic implants. They become reservoirs for persistent 
infections and foci for metastatic complications such as endocarditis, deep tissue 
abscesses, septic arthritis, and osteomyelitis (Costerton et al., 1999; Chu et al., 2005). 
Definitive management of device-related infection frequently requires removal or 
replacement of the prosthetic material. 
 
The best-described mechanism of biofilm development in S. aureus involves the 
extracellular molecule polysaccharide intercellular adhesin or poly-N-
acetylglucosamine (PIA/PNAG) (Mack et al., 1996). PIA/PNAG synthesis is 
regulated by the intercellular adhesion (ica) locus (Cramton et al., 1999). PIA/PNAG 
and ica-independent biofilm formation, particularly in MRSA, has also been 
described (Fitzpatrick et al., 2005; O’Neill et al., 2008).However, the relationship 
between biofilm formation and the genetic background of S. aureus is poorly 
understood. Different clonal lineages of S. aureus may have different biofilm forming 
capabilities. In the recent literature, differences in biofilm formation were found to be 
due to the staphylococcus protein A (spa) lineage (Atshan et al., 2012a). Other studies 
found strong biofilm formation correlated with multilocus sequence typing (MLST) 
clonal complexes (Croes et al., 2009) or Staphylococcal Chromosome Cassette mec 
(SCCmec) typing (Lim et al., 2013). 
   
This study investigated the association between the genetic background and the 
biofilm forming ability of clinical invasive S. aureus isolates. In addition, we 
investigated any correlation with biofilm formation and methicillin resistance or 




Setting & Design. This was a prospective, descriptive study conducted at the 
National Health Laboratory Service (NHLS) Microbiology Laboratory, Tygerberg 
Hospital, which is a 1300-bed tertiary referral hospital in Cape Town, South Africa.  




Bacterial strains. S. aureus isolates obtained from pure blood cultures between 
January 2010 and January 2012 were included. Positive blood cultures were identified 
using the BACTEC 9240 system (Becton Dickinson, USA). Identification of S. 
aureus was done using Mannitol Salt agar (MSA) and DNase agar plates or Vitek 2 
(bioMérieux, Marcy l’Etoile, France).  Kirby-Bauer disk diffusion antimicrobial 
susceptibility testing was performed and Vancomycin Minimum Inhibitory 
Concentrations (MIC) were determined using ETests (bioMérieux, France) for all 
MRSA isolates. Clinical and Laboratory Standards Institute (CLSI) 2010 and 2011 
interpretative criteria were used. Isolates were stored on Microbeads in cryobroth at  
-70°C until defrosted and sub-cultured onto blood agar plates for use in this study. 
 
Genotypic characterization. Pulsed-field gel electrophoresis (PFGE) is considered 
the reference standard for S. aureus strain typing and is the most discriminatory 
typing method (Deurenberg et al., 2007; Oosthuysen et al., 2013). The method 
described by McDougal et al. was followed (McDougal et al., 2003). The clones were 
classified based on the number of isolates and unique PFGE types as major (> 10 
isolates per PFGE type), intermediate (4-9 isolates per PFGE type) or minor (2-3 
isolates per PFGE types). In addition, spa typing and SCCmec typing were also 
performed (Harmsen et al., 2003; Milheirico et al., 2007). MLST was performed on a 
representative set of isolates from each major PFGE cluster (Enright et al., 2000).   
 
Isolate selection. From a total collection of 208 non-repeat isolates, blood culture 
isolates were selected from each major, intermediary and some minor PFGE clusters. 
Different spa types within the same cluster were also selected. For MRSA isolates, 
isolates from the same PFGE clusters and spa type were only selected if they were 
different on SCCmec typing. To include more PFGE clusters, a singleton and different 
spa types, 2 isolates were included even though MLST data was not available (Table 
1). 
 
MLST CC MLST ST  spa-CC  spa types  SCCmec  
CC1  
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t008, t037(2)  
 
III, IV(2), V, 
untypeable 













(2) ST22(2) cc022(2) t891, t032 IV 




(2) ST36, ST1865 cc021(2) t012, t318 II 
CC45 
(2) ST45(2) cc015/073(2) t073, t015 - 
CC97 ST97 cc267 t359 - 
- 
- - - cc084 singleton t084 t148 - 
- 
  Table 1. Genotypic characteristics of strains *Number in parentheses (if >1) 
 
 
Biofilm assay. Thirty genotypically unique strains were assessed for phenotypic 
biofilm formation with the microtitre plate assay as described by Christensen et al and 
modified by O’Neill et al (Christensen et al., 1985; O’Neill et al., 2007). Briefly, S. 
aureus was grown overnight in Brain Heart Infusion (BHI) broth. The culture was 
diluted 1:200 in fresh BHI broth. An amount of 200µL was added to a 96-well 
polystyrene tissue-culture treated microtitre plate (Costar® 3595, Corning 
Incorporated, NY, USA) and incubated at 37°C for 24 hours. After overnight 
incubation the wells were manually rinsed three times with Phosphate-Buffered Saline 
(PBS), using a hand-held pipette. The plates were air-dried at 60°C for one hour to fix 
the remaining cells. These were then stained with 0.4% Crystal Violet for two minutes 
and the plate was rinsed three times with PBS once again. The optical density was 
measured with a MicroELISA plate reader at a wavelength of 490nm (iMark 
Microplate Absorbance Reader, Bio-Rad, USA). All isolates were tested in triplicate 
and an average optical density was determined. A cutoff of 0.17 was used as it was 
three standard deviations above the mean for a clean tissue culture plate stained as 
above. Isolates with A490 ≤ 0.17 were considered non-adherent. A490 > 0.17 was 
considered Weak positive and A490 > 0.34 Strong positive (twice the cutoff value). S. 
epidermidis ATCC 35984 (American Type Culture Collection, Virginia USA) and 
Brain Heart Infusion broth were used as positive and negative controls respectively. 
 
Clinical data. Clinical information was obtained by clinical consultation with the 
attending doctor as part of the routine microbiology service for all positive blood 
cultures. Informed consent was obtained from patients and clinical data was stored in 
a database with study numbers used for patient confidentiality. Folder reviews were 
conducted for select cases where insufficient clinical information was gathered. The 
source of bacteraemia was determined according to the clinical presentation, 
radiological features and bacteriological factors i.e. the isolation of S. aureus from 
specimens from the site of infection (Orth et al., 2013). The categories were defined 
as follows: skin and soft tissue (SSTI) was the clinical presentation of soft tissue 
inflammation together with bacteraemia. Catheter-related blood stream infection 
(CRBSI) was determined by the culture of S. aureus from the catheter tip (>10
2
 cfu) 
and/or clinical evidence of catheter related infection. Pneumonia (PNEUM) was the 
isolation of S. aureus from the respiratory tract with compatible radiological features. 
Modified Duke’s criteria was used to define infective endocarditis (IE). Bone and 
joint (B&J) was clinical and radiological features of osteomyelitis or septic arthritis. 
Vascular (VASC) was clinical evidence of endovascular infection and intra-
abdominal (IA) was defined as clinical and radiological evidence of deep-seated intra-
abdominal source with S. aureus cultured from the site (Liao et al., 2008). 




Statistical analysis. ANOVA with Bonferroni-adjusted post-hoc tests and t-tests were 
used for statistical analysis (Statistica version 10, 2011). The biofilm forming ability 
was analyzed by methicillin resistance, source of bacteraemia, spa, SCCmec and 
MLST type. Statistical significance was defined as p <0.05. 
 
Ethics. This study received ethical approval from the Division of Research 




A. Description of isolates 
 
The 30 isolates selected comprised of 19 PFGE clusters, with 28 spa types and 15 
MLST sequence types (ST). These were from 9 spa-clonal complexes (spa-CC) and 9 




















1 1 cc174 t127 Z  SSTI 0.19 WEAK 
1 1 cc174 t5471 Z  CRBSI 0.22 WEAK 
1 1 cc174 t174 AF  SSTI 0.14 NON 
1 1 cc174 t8637 AF  B&J 0.19 WEAK 
5 5 cc002 t045 M I CRBSI 0.15 NON 
5 5 cc002 t570 Y  B&J 0.12 NON 
5 6 cc064 t2360 AE  CRBSI 1.06 STRONG 
5 6 cc064 t701 AE  CRBSI 0.39 STRONG 
5 461 cc002 t045 N I CRBSI 0.1 NON 
5 2122 cc002 t002 W  SSTI 0.2 WEAK 
5 2122 cc002 t071 W  VASC 0.18 WEAK 
8 8 cc064 t1476 Q  VASC 0.51 STRONG 
8 8 cc064 t008 O V SSTI 0.13 NON 
8 239 cc021 t037 U III SSTI 0.18 WEAK 
8 239 cc021 t037 U untypeable PNEUM 0.12 NON 
8 612 cc064 t1443 S IV CRBSI 0.39 STRONG 
8 612 cc064 t1257 S IV SSTI 0.51 STRONG 
12 12 cc160 t160 AB  PNEUM 0.2 WEAK 
15 2126 cc084 t084 AA  CRBSI 0.12 NON 
15 2126 cc084 t279 AA  IE 0.25 WEAK 
15 2126 cc084 t094 AA  SSTI 0.12 NON 
22 22 cc022 t891 G  SSTI 0.18 WEAK 
22 22 cc022 t032 G IV IA 0.26 WEAK 
30 36 cc021 t012 B II SSTI 0.19 WEAK 
30 1865 cc021 t318 A  IE 0.15 NON 
45 45 cc015/073 t073 D  IA 0.12 NON 
45 45 cc015/073 t015 D  SSTI 0.09 NON 
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97 97 cc267 t359 P  CRBSI 0.13 NON 
    cc084 t084 SINGL#  CRBSI 0.3 WEAK 
    SINGL# t148 I  PNEUM 0.1 NON 
Table 2: Genotypic characterization and biofilm formation  
*(SSTI = skin and soft tissue; CRBSI = catheter-related blood-stream infections; PNEUM = pneumonia; B&J = bone and joint; 
 IA = intra-abdominal; VASC = vascular; IE = infective endocarditis) 
#Singleton 
Stellenbosch University  http://scholar.sun.ac.za
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There were 9 MRSA (30%) and 21 methicillin-sensitive S. aureus (MSSA) (70%). 
The source of infection was determined for all the S. aureus bacteraemias (Figure 1). 
Ten originated from skin and soft tissue infections (SSTI), 9 from catheter-related 
blood-stream infections (CRBSI), 3 pneumonias (PNEUM), and 2 each from infective 
endocarditis (IE), bone and joint (B&J), vascular (VASC) and intra-abdominal (IA). 
 
 
                                   Figure 1. Source of bacteraemia  
(SSTI = skin and soft tissue; CRBSI = catheter-related blood-stream infections; PNEUM = pneumonia; B&J = 
bone and joint; IA = intra-abdominal; VASC = vascular; IE = infective endocarditis) 
 
Biofilm formation occurred in 57% of isolates (Figure 2). Weak biofilm formation 
occurred in 40% (n=12) and strong biofilm formation in 17% (n=5) of isolates. 




                                       Figure 2. Biofilm categories 
 
B. Analysis by genetic background. 
 
           i) spa typing 
 
The spa types t701, t1275, t1443, t1476 and t2360 were strong biofilm producers. 
There were too many individual spa types for further analysis.  
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All 5 isolates capable of strong biofilm formation belong to one spa clonal complex 
(spa-CC 064). Strains from spa-CC 064 were capable of higher biofilm formation 








                              Figure 4. Biofilm categories and spa-CC 
 
        ii) MLST  
 
MLST ST6, ST8 and ST612 produced strong biofilms. Generally the category of 
biofilm production correlated with the MLST sequence types.  
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Strains from MLST CC 1, 5, 8, 12, 15, 22 and 30 were capable of biofilm formation. 
Although there was no difference found with biofilm formation and MLST CC 
(p=0.89), MLST CC5 and CC8 isolates had a higher biofilm forming capacity. The 5 
strong biofilm producers (all from spa-CC064) fell into MLST CC5 and CC8 (Figure 
5 & 6).  
 
 
Figure 5. Average OD and MLST CC 
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          iii) SCCmec typing 
 
There were only 9 MRSA isolates for SCCmec typing and further analysis could not 
be performed.  
 
       iv) PFGE 
 
As PFGE strain typing was the basis of selection of isolates, biofilm formation could 
not be analysed by PFGE clusters due to the large variation. 
 
C. Analysis by methicillin resistance 
 
There were no significant differences observed in biofilm formation of MRSA isolates 
compared with MSSA isolates (p=0.9) (Figure 7 & 8). 
 
                  

























Figure 7. Optical density for MRSA and MSSA isolates 
 
 




                      Figure 8.  Biofilm categories by Methicillin resistance 
 
 
D. Analysis by source of bacteraemia 
 
There were no differences in biofilm formation relating to the source of bacteraemia 
(p=0.64). However, as clinically expected, it was observed that VASC and CRBSI 
infections had higher median optical densities. The sources of bacteraemia for strong 




                    Figure 9. Optical density and source of bacteraemia 










Biofilm-associated infections caused by S. aureus are a significant cause of morbidity 
and mortality (Archer et al., 2011). In this study strong biofilm formation was 
associated with strains from spa-CC 064 and MLST CC 5 and 8. Although MLST 
CC8 has now been incorporated into MLST CC5, it is considered separately in this 
analysis (Oosthuysen et al., 2013). As MLST CC8 in now incorporated into MLST 
CC5, MLST CC5 may be associated with high biofilm formation. This suggests that 
certain clones are more prone to biofilm formation and that spa-typing and MLST 
may be a predictor of biofilm formation. 
 
S. aureus demonstrates predominantly clonal evolution. Virulence factors may be 
associated with specific S. aureus lineages. Certain virulence factors such as collagen 
adhesion (CNA) and toxic shock syndrome toxin 1 (TSST1) are known to be 
associated with certain clonal lineages (Deurenberg et al., 2009). Therefore some 
clones are considered more virulent than others (Melles et al., 2004). Biofilm 
formation is also a major virulence factor and several other observations have 
supported the link between the clonal lineage and biofilm formation. 
 
Atshan et al. found that strains from the same spa type had similar adherence 
properties on the microtitre plate assay. In another study by the same group, MRSA 
strains from the same MLST, spa and SCCmec type had similar biofilm forming 
abilities, however there was more variation by spa type. In contrast to our findings, 
they found spa type t037 (ST239-CC8-IIIA) strains form strong biofilms (Atshan et 
al., 2012a,b). Croes et al. suggested that MLST CC8 was a predisposing factor for a 
strain to produce strong biofilms (Croes et al., 2009). Furthermore, the Brazilian clone 
(also MLST CC8) was shown to have increased adherence (Amaral et al., 2005). The 
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EMRSA-15 clone in Scotland was found to form stronger biofilms than EMRSA-16 
isolates (Smith et al., 2008).  
 
In two South African academic hospitals it was shown that MRSA bacteraemia had a 
higher mortality rate than MSSA (Perovic et al., 2006). The prevalence of MRSA in 
bacteraemia at Tygerberg hospital has been reported to be 30% (Orth et al., 2013), 
which is reflected in the percentage of MRSA in the collection of strains that we 
tested. Certain pandemic MRSA clones are spread worldwide. Recent publications 
describe the ST612-MRSA-IV clone (MLST CC8) as the most widespread MRSA 
clone in Cape Town, and South Africa (Jansen van Rensburg et al., 2011; Orth et al., 
2013; Oosthuysen et al., 2013; Moodley et al., 2010). In this study ST 612 formed 
strong biofilms, which may contribute to its dominance in nosocomial infections in 
South Africa.  
 
Some studies found SCCmec typing a predictor of biofilm formation. SCCmec IV 
isolates were capable of higher biofilm formation (Kwon et al., 2008). In contrast to 
the findings by Lim et al. where SCCmec III was found to be a genetic risk factor for 
strong biofilm formation (Lim et al., 2013), we found SCCmec IV isolates produced 
the strongest biofilms (only three isolates tested). In our study the one SCCmec III 
isolate did form a weak biofilm. The differences found could also be attributed to the 
biofilm assay methodology. A larger collection of MRSA isolates should be tested to 
make any meaningful conclusions. 
  
Kwon et al. demonstrated that MRSA clinical isolates had a greater likelihood of 
developing biofilms. Approximately 37.9% of the 66 MRSA formed biofilms 
compared to 14.3% of the 35 MSSA tested (p<0.05) (Kwon et al., 2008). Other 
studies showed no difference in biofilm formation between MRSA and MSSA 
isolates (Smith et al., 2008; Indrawattana et al., 2013). In our study there was also no 
difference in biofilm formation between MRSA and MSSA isolates, although the 
mean optical density for MSSA was higher. Atshan et al. also found MSSA clones 
had slightly higher biofilm formation than MRSA. Croes et al. found that MRSA or 
MSSA with an MRSA associated CC, were more capable of strong biofilm formation 
in the presence of 0.1% glucose. Our study did not supplement glucose which may 
have affected the MRSA biofilm capabilities. Our selection criteria was based on the 
genotypic classification which is also a limiting factor as some clones may be 
associated with methicillin-resistance (Deurenberg et al., 2007). 
 
Several studies have investigated the source of isolates as a predictor of biofilm 
formation.  Isolates from blood cultures showed a higher frequency of biofilm 
formation compared to isolates from other sites (Kwon et al., 2008). In the study by 
Smith et al., the isolates derived from skin had a greater ability to form fully 
established biofilms (Smith et al., 2008). In our study, the source of bacteraemia as 
established by clinical data for S. aureus blood-stream infections was not a predictor 
of biofilm formation. However, we only tested blood culture isolates, these being the 
most clinically important specimens, and did not collect isolates from the source of 
infection. 
 
The variations in biofilm capacity may be due to differences in surface proteins or 
gene expression in different S. aureus clonal lineages. Microarray analysis showed 
variation between different lineages is, in particular, due to surface adhesion genes 
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and their regulators. However there were no specific genes to differentiate carriage 
versus invasive isolates (Lindsay et al., 2006). Kuhn et al. also found no difference 
with adhesion genes in epidemic and sporadic MRSA clones (Kuhn et al., 2006). 
Gene expression studies and whole genome sequencing may assist to elucidate the 
reason for these differences (Costa et al., 2013). 
 
The strength of this study was that biofilm formation was tested on a collection of 
genotypically well characterized strains, all of them isolated from blood cultures. 
They were selected to be genetically diverse. PFGE, the gold standard for S. aureus 
strain typing, was the basis of the selection to ensure that we did not test the same 
strain as outbreaks of MRSA may occur in hospital settings. Strains within the same 
PFGE cluster were chosen if they were different spa or SCCmec types. The 
limitations were the small numbers included. By testing more isolates we could have 
also assessed if certain spa-types are more prone to biofilm formation. Another 
limiting factor was not using supplementary glucose in the biofilm assay. This may 
influence the MRSA biofilm formation (Croes et al., 2009; O’Neill et al., 2007). 
Although we did analyse our collection by methicillin resistance and source of 
bacteraemia, these were secondary objectives. The limitation of selecting isolates 
based on their genetic background is that conclusions cannot be made about 
methicillin resistance and source of bacteraemia. Further studies should be conducted 
with different selection criteria to specifically address these questions. Further 
investigations for the presence of adhesion genes, gene expression and accessory gene 
regulator (agr) groups are required. 
 
Biofilm formation correlates with genetic background in our population of invasive S. 
aureus strains. The propensity to form biofilms may be linked to the epidemic 
potential of certain successful clones of S. aureus. The spa lineage may serve as a 
genetic predictor of biofilm formation. MLST can also be used to determine clones 
with higher biofilm formation. Further studies are required to identify these clones 
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